🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, double-blind, placebo-controlled, flexible dose study to eval...
Status
Completed
Location
248.644.0026 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00558467
Treatments Being Tested
The primary objective of this study is to determine the efficacy of pramipe...
Status
Completed
Location
248.604.35801 Boehringer Ingelheim Investigational Site
Start Date
2006-07
Trial ID
NCT00356096
Treatments Being Tested
This study will assess the efficacy and safety of dexpramipexole as an adju...
Status
Terminated
Location
Research Site 20001-374
Start Date
2023-01-30
Trial ID
NCT05763121
Treatments Being Tested
The primary objective is to assess sustained efficacy in patients who have ...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2004-01
Trial ID
NCT00152958
Treatments Being Tested
To determine efficacy and safety of Pramipexole 0.125mg to 0.75mg daily for...
Status
Completed
Location
248.630.04 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00654498
Treatments Being Tested
The objectives of this trial conducted in early Parkinson's Disease (PD) pa...
Status
Completed
Location
248.524.01018 Boehringer Ingelheim Investigational Site
Start Date
2007-05
Trial ID
NCT00479401
Treatments Being Tested
This is a Phase 2a, placebo-controlled, single-blind study in up to 24 pati...
Status
Unknown
Location
Collaborative Neuroscience Network
Start Date
2018-09-10
Trial ID
NCT03642964
Treatments Being Tested
The purposes of this study are as follows: 1. To assess the cardiovascular ...
Status
Completed
Location
Michael E. DeBakey VA Medical Center
Start Date
2011-10
Trial ID
NCT01651377
Treatments Being Tested
This was a 2-part study of dexpramipexole in patients with ALS. Part 1 was...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2008-04-09
Trial ID
NCT00647296
Treatments Being Tested
The objectives of the studies are: * To demonstrate similar total exposure...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02261103